<Header>
<FileStats>
    <FileName>20241231_10-Q_edgar_data_1584480_0001640334-24-001969.txt</FileName>
    <GrossFileSize>1784962</GrossFileSize>
    <NetFileSize>29945</NetFileSize>
    <NonText_DocumentType_Chars>384375</NonText_DocumentType_Chars>
    <HTML_Chars>406134</HTML_Chars>
    <XBRL_Chars>377791</XBRL_Chars>
    <XML_Chars>552715</XML_Chars>
    <N_Exhibits>7</N_Exhibits>
</FileStats>
<SEC-Header>
0001640334-24-001969.hdr.sgml : 20241231
<ACCEPTANCE-DATETIME>20241231124842
ACCESSION NUMBER:		0001640334-24-001969
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		38
CONFORMED PERIOD OF REPORT:	20241130
FILED AS OF DATE:		20241231
DATE AS OF CHANGE:		20241231

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Startech Labs, Inc.
		CENTRAL INDEX KEY:			0001584480
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-56158
		FILM NUMBER:		241592070

	BUSINESS ADDRESS:	
		STREET 1:		244 MADISON AVENUE
		CITY:			NEW YORK CITY
		STATE:			NY
		ZIP:			10016-2817
		BUSINESS PHONE:		(802) 255-4212

	MAIL ADDRESS:	
		STREET 1:		244 MADISON AVENUE
		CITY:			NEW YORK CITY
		STATE:			NY
		ZIP:			10016-2817

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UpperSolution.com
		DATE OF NAME CHANGE:	20130814

</SEC-Header>
</Header>

 0001640334-24-001969.txt : 20241231

10-Q
 1
 laab_10q.htm
 FORM 10-Q

laab_10q.htm 
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended or TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File Number (Exact name of registrant as specified in its charter) N/A (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) , , (Address of principal executive offices) (Zip Code) ) (Registrant s telephone number, including area code) ___________________________________________________________ (Former name, former address and former fiscal year, if changed since last report) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. No Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes No APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PRECEDING FIVE YEARS Check whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Exchange Act after the distribution of securities under a plan confirmed by a court. Yes No APPLICABLE ONLY TO CORPORATE ISSUERS Indicate the number of shares outstanding of each of the issuer s classes of common stock, as of the latest practicable date. common shares issued and outstanding as of December 27, 2024 FORM 10-Q TABLE OF CONTENTS PART I - FINANCIAL INFORMATION Item 1. Financial Statements 3 Item 2. Management s Discussion and Analysis of Financial Condition and Results of Operations 12 Item 3. Quantitative and Qualitative Disclosures About Market Risk 14 Item 4. Controls and Procedures 14 PART II - OTHER INFORMATION Item 1. Legal Proceedings 15 Item 1A. Risk Factors 15 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 15 Item 3. Defaults Upon Senior Securities 15 Item 4. Mine Safety Disclosures 15 Item 5. Other Information 15 Item 6. Exhibits 16 SIGNATURES 17 2 Table of Contents PART I - FINANCIAL INFORMATION Item 1. Financial Statements STARTECH LABS, INC. BALANCE SHEETS (UNAUDITED) November 30, May 31, 2024 2024 ASSETS Current Assets Total Current Assets Intangible Assets Total Assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued liabilities Accrued interest Due to related party Convertible notes Total Current Liabilities Total Liabilities STOCKHOLDERS' DEFICIT Common Stock: par value, shares authorized, shares issued and outstanding Additional paid-in capital Accumulated deficit Total Stockholders' Deficit TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT The accompanying notes are an integral part of these unaudited condensed financial statements. 3 Table of Contents STARTECH LABS, INC. STATEMENTS OF OPERATIONS (UNAUDITED) For the Three Months Ended For the Six Months Ended November 30, November 30, November 30, November 30, 2024 2023 2024 2023 Operating Expenses General and administration Professional Total operating expenses Net loss from operations Other expense Interest expense Total other expense Net loss before taxes Provision for income taxes Net loss Net Loss Per Common Share Basic and Diluted Weighted Average Common Shares Outstanding The accompanying notes are an integral part of these unaudited condensed financial statements. 4 Table of Contents STARTECH LABS, INC. STATEMENT OF STOCKHOLDERS DEFICIT FOR THE SIX MONTHS ENDED NOVEMBER 30, 2024 AND 2023 (UNAUDITED) Six Months Ended November 30, 2024 Additional Total Common stock Paid-in Accumulated Shareholders' Shares Amount Capital Deficit Deficit Balance, May 31, 2024 Net loss - Balance, August 31, 2024 Net loss - Balance, November 30, 2024 Six Months Ended November 30, 2023 Additional Total Common stock paid-in Accumulated Shareholders' Shares Amount capital Deficit Deficit Balance, May 31, 2023 Net loss - (26,786 Balance, August 31, 2023 Net loss - Balance, November 30, 2023 The accompanying notes are an integral part of these unaudited condensed financial statements. 5 Table of Contents STARTECH LABS, INC. STATEMENTS OF CASH FLOWS (UNAUDITED) For the Six Months Ended November 30, November 30, 2024 2023 Cash Flows from Operating Activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Changes in operating assets and liabilities: Accounts payable Accrued interest Net Cash Used in Operating Activities Cash Flows from Financing Activities: Advancement from director Net Cash Provided by Financing Activities Net Change in Cash and Cash Equivalents Cash and Cash Equivalents, beginning of period Cash and Cash Equivalents, end of period Supplemental Disclosure Information: Cash paid for interest Cash paid for taxes The accompanying notes are an integral part of these unaudited condensed financial statements. 6 Table of Contents STARTECH LABS, INC. NOTES TO THE UNAUDITED FINANCIAL STATEMENTS NOVEMBER 30, 2024 7 Table of Contents Basic and Diluted Net Loss Per Share Fair Value of Financial Instruments 8 Table of Contents Share-based Expenses Recent Accounting Pronouncements and has negative working capital of at November 30, 2024. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plan described in the Business paragraph and eventually attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern. During the next year, the Company s foreseeable cash requirements will relate to continual development of the operations of its business, maintaining its good standing and making the requisite filings with the Securities and Exchange Commission, and the payment of expenses associated with research and development. The Company may experience a cash shortfall and be required to raise additional capital. 9 Table of Contents shares of common stock with a par value of . As of November 30, 2024 and May 31, 2024, shares of common stock were issued and outstanding. and for operating expenses on behalf of the Company, respectively. The loan is non-interest bearing and due on demand. As of November 30, 2024 and May 31, 2024, the amount due to director was and respectively. Convertible Notes - August 2019 Convertible Notes - November 2019 Convertible Notes - February 2020 Convertible Notes - May 2020 Convertible Notes - August 2020 Convertible Notes - November 2020 Convertible Notes - February 2021 Less current portion of convertible notes payable Non-current convertible notes payable On June 1, 2019, the Company issued convertible notes to three unaffiliated parties for an aggregate amount of to replace the full amount of related party advances that had been provided to the Company through May 31, 2019. The convertible notes are due on demand, bear interest at per annum and are convertible at per share for the Company common stock. The total debt discount from the beneficial conversion features of was expensed upon issuance of the notes. On August 31, 2019, the Company issued a convertible note to an unaffiliated party of for paying operating expenses on behalf of the Company. The convertible note is due on demand, bears interest at per annum and is convertible at per share for the Company common stock. The debt discount from the beneficial conversion of was expensed upon issuance of the note. 10 Table of Contents for paying operating expenses on behalf of the Company. The convertible note is due on demand, bears interest at per annum and is convertible at per share for the Company common stock. The debt discount from the beneficial conversion of was expensed upon issuance of the note. On January 3, 2020, the Company amended a convertible note of issued on June 1, 2019. The amended convertible note is due on demand, bear interest at per annum and are convertible at per share for the Company common stock. On February 17, 2020, the note holder of the amended convertible note sold the note to two unaffiliated parties. On June 1, 2020, principal of from the convertible notes was converted for shares of common stock. On February 29, 2020, the Company issued a convertible note to an unaffiliated party of for paying operating expenses on behalf of the Company. The convertible note is due on demand, bears interest at per annum and is convertible at per share for the Company common stock. The debt discount from the beneficial conversion of was expensed upon issuance of the note. On May 31, 2020, the Company issued a convertible note to an unaffiliated party of for paying operating expenses on behalf of the Company. The convertible note is due on demand, bears interest at per annum and is convertible at per share for the Company common stock. The debt discount from the beneficial conversion of was expensed upon issuance of the note. On August 31, 2020, the Company issued a convertible note to an unaffiliated party of for paying operating expenses on behalf of the Company. The convertible note is due on demand, bears interest at per annum and is convertible at per share for the Company common stock. The debt discount from the beneficial conversion of was expensed upon issuance of the note. On November 30, 2020, the Company issued a convertible note to an unaffiliated party of for paying operating expenses on behalf of the Company. The convertible note is due on demand, bears interest at per annum and is convertible at per share for the Company common stock. The debt discount from the beneficial conversion of was expensed upon issuance of the note. On February 28, 2021, the Company issued a convertible note to an unaffiliated party of for paying operating expenses on behalf of the Company. The convertible note is due on demand, bears interest at per annum and is convertible at per share for the Company common stock. The debt discount from the beneficial conversion of was expensed upon issuance of the note. During the six months ended November 30, 2024 and 2023, the Company incurred note interest expense of and , respectively. As of November 30, 2024 and May 31, 2024, the convertible notes payable was and , respectively, and accrued note interest payable was and , respectively. 11 Table of Contents Item 2. Management s Discussion and Analysis of Financial Condition and Results of Operations FORWARD-LOOKING STATEMENTS This quarterly report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as may , should , expects , plans , anticipates , believes , estimates , predicts , potential or continue or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results. Our unaudited financial statements are stated in United States Dollars (US and are prepared in accordance with United States Generally Accepted Accounting Principles. The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this quarterly report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below and elsewhere in this quarterly report. Unless otherwise specified in this quarterly report, all dollar amounts are expressed in United States dollars and all references to common stock refer to shares of our common stock. As used in this quarterly report, the terms we , us , our company , mean Startech Labs, Inc., a Nevada corporation, unless otherwise indicated. Overview We were incorporated in the State of Nevada on April 20, 2013 under the name UpperSolution.com with the principal business objective of creating an independent and unbiased mobile app that enables consumers to find the best cellular rate plan for their need and getting real-time notifications when a new cellular plan is available. On January 10, 2018, our company, Analog Nest Technologies, Inc. Analog Nest and the shareholders of Analog (the Analog Nest Shareholders closed a transaction pursuant a share exchange agreement dated January 10, 2018, whereby our company acquired 100 of the outstanding shares of common stock of Analog Nest (the Analog Nest Stock from the Analog Nest Shareholders. In exchange for the Analog Nest Stock our company issued 100,000 shares of our common stock to the Analog Nest Shareholders. Analog Nest was incorporated in the State of Nevada on September 8, 2017 as a mobile application app company focused on utility/entertainment apps for Google s Android and Apple s iOS platforms. In December 2017, Analog Nest acquired the following apps: Old Fart Booth, Old Fart Booth Pro, Ugly Face Booth, Ugly Santa Booth, Baldy Bald Photo Booth, Fatty Make Funny Fat Faces, Slender Man Scary Prank, Anime Booth, Anime Booth Free, Minecart Mayhem, Pimp My Pet, Pimp My Dog, Cavity Detector Scary Prank, Mustacher, Alex From Target, A Farm Animal Salon, Mustacher Pro, Pimp My Cat, and Animal Dress Up Salon. On June 26, 2019, a majority of our stockholders and our board of directors approved a change of name of our company to Startech Labs, Inc. and a reverse stock split of our issued and outstanding shares of common stock on a ninety-five (95) old for one (1) new basis. The name change and reverse stock split became effective on July 17, 2019. We have not declared bankruptcy, been involved in receivership or any similar proceeding. Our office is located at 244 Madison Avenue, New York, NY 10016-2817 and our telephone number is (802) 255-4212. We do not own any property and we do not have a corporate website. Our Current Business Startech Labs develops customized web solutions with both commercial and retail applications. Currently focused on further development of fare aggregators and travel metasearch engines, Startech Labs owns and operates international online travel and hospitality web portals where users can search for flights and hotels and select the most economical options. Results of Operations The following summary of our operations should be read in conjunction with our unaudited financial statements for the six months ended November 30, 2024 and 2023. 12 Table of Contents Three months ending November 30, 2024 compared to three months ending November 30, 2023: For the Three Months Ended November 30, November 30, 2024 2023 Change Operating Expenses 4,559 6,233 (1,674 (27 Other expense 7,368 7,368 - - Net Loss (11,927 (13,601 1,674 (12 Net loss totalled 11,927 for the three months ended November 30, 2024, compared to a net loss for the three months ended November 30, 2023 of 13,601. The decrease in net loss was mainly due to the decrease in professional fees. Six months ending November 30, 2023 compared to six months ending November 30, 2022: For the Six Months Ended November 30, November 30, 2024 2023 Change Operating Expenses 22,097 25,571 (3,474 (14 Other expense 14,816 14,816 - - Net Loss (36,913 (40,387 3,474 (9 Net loss totalled 36,913 for the six months ended November 30, 2024, compared to a net loss for the six months ended November 30, 2023 of 40,387. The decrease in net loss was mainly due to the decrease in professional fees. Liquidity and Capital Resources Working Capital November 30, May 31, 2024 2024 Change Current Assets - - - Current Liabilities 410,626 373,713 36,913 Working Capital Deficiency (410,626 (373,713 (36,913 The increase in working capital deficiency during the six months ended November 30, 2024 was primarily a result of an increase of due to related parties and accrued interest payable. Cash Flows For the Six Months Ended November 30, November 30, 2024 2023 Cash Flows used in Operating Activities (17,681 (22,617 Cash Flows used in Investing Activities - - Cash Flows from Financing Activities 17,681 22,617 Net Change in Cash and Cash Equivalents - - 13 Table of Contents Cash Flow from Operating Activities During the six months ended November 30, 2024, our Company used 17,681 in cash from operating activities, compared to 22,617 cash used in operating activities during the six months ended November 30, 2023. The cash used from operating activities for the six months ended November 30, 2024 was attributed to a net loss of 36,913, reduced by changes in operating assets and liabilities of 19,232. The cash used from operating activities for the six months ended November 30, 2024 was attributed to a net loss of 40,387, reduced by changes in operating assets and liabilities of 17,770. Cash Flow from Investing Activities During the six months ended November 30, 2024 and 2023, our company did not use any cash in investing activities. Cash Flow from Financing Activities During the six months ended November 30, 2024 and 2023, our company received 17,681 and 22,617 from director s advancement, respectively. Off-Balance Sheet Arrangements We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders. Going Concern We have incurred net loss since our inception on April 20, 2013 through November 30, 2024 totalling 39,125,896 and have completed only the preliminary stages of our business plan. We anticipate incurring additional losses before realizing any revenues and will depend on additional financing in order to meet our continuing obligations and ultimately, to attain profitability. Our ability to obtain additional financing, whether through the issuance of additional equity or through the assumption of debt, is uncertain. Accordingly, our independent auditors report on our financial statements for the year ended May 31, 2024 includes an explanatory paragraph regarding concerns about our ability to continue as a going concern, including additional information contained in the notes to our financial statements describing the circumstances leading to this disclosure. The financial statements do not include any adjustments that might result from the uncertainty about our ability to continue our business. Recently Issued Accounting Pronouncements We do not expect the adoption of any recently issued accounting pronouncements to have a significant impact on our net results of operations, financial position, or cash flows. Item 3. Quantitative and Qualitative Disclosures About Market Risk As a smaller reporting company , we are not required to provide the information required by this Item. Item 4. Controls and Procedures Disclosure Controls and Procedures Our management, with the participation of our Chief Executive Officer (our principal executive officer, principal financial officer and principal accounting officer), has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a- 15(e) and 15d- 15(e) under the Securities Exchange Act of 1934, as amended (Exchange Act)), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Chief Executive Officer has concluded that as of such date, our disclosure controls and procedures were not effective such that the information relating to us required to be disclosed in our Securities and Exchange Commission SEC reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting During the period covered by this report there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 14 Table of Contents PART II - OTHER INFORMATION Item 1. Legal Proceedings We know of no material, existing or pending legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered beneficial shareholder, is an adverse party or has a material interest adverse to our interest. Item 1A. Risk Factors As a smaller reporting company , we are not required to provide the information required by this Item. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds None. Item 3. Defaults Upon Senior Securities None. Item 4. Mine Safety Disclosures Not applicable. Item 5. Other Information None 15 Table of Contents Item 6. Exhibits INCORPORATED BY REFERENCE EXHIBIT NUMBER Exhibit Description Form Exhibit Filing Date (3) (i) Articles of Incorporation, (ii) Bylaws 3.1 Articles of Incorporation 10-K 3.1 August 21, 2019 3.2 By-Laws S-1 3.2 August 16, 2013 3.3 Certificate of Amendment 10-K 3.3 August 21, 2019 (31) (i) Rule 13a-14(a)/15d-14(a) Certifications, (ii) Rule 13a-14/15d-14 Certifications 31.1 Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Executive Officer and Chief Financial Officer (32) Section 1350 Certifications 32.1 Section 1350 Certification of Chief Executive Officer and Chief Financial Officer (100) Interactive Data File 101.INS XBRL Instance Document 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document 101.LAB XBRL Taxonomy Extension Label Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document _________ Filed herewith. Furnished herewith. 16 Table of Contents SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. STARTECH LABS, INC. (Registrant) Dated: December 31, 2024 /s/ Kevin So Kevin So President, Chief Executive Officer, Secretary and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) 17 

<EX-31.1>
 2
 laab_ex311.htm
 CERTIFICATION
 
 laab_ex311.htm EXHIBIT 31.1 CERTIFICATION PURSUANT TO 18 U.S.C. ss 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Kevin So, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Startech Labs, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant s internal control over financial reporting that occurred during the registrant s most recent fiscal quarter (the registrant s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant s internal control over financial reporting; and 5. The registrant s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant s auditors and the audit committee of the registrant s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant s internal control over financial reporting. Date: December 31, 2024 /s/ Kevin So Kevin So President, Chief Executive Officer, Secretary and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) 

</EX-31.1>

<EX-32.1>
 3
 laab_ex321.htm
 CERTIFICATION
 
 laab_ex321.htm EXHIBIT 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Kevin So, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: (1) the Quarterly Report on Form 10-Q of Startech Labs, Inc. for the period ended November 30, 2024 (the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Startech Labs, Inc. Dated: December 31, 2024 /s/ Kevin So Kevin So President, Chief Executive Officer, Secretary and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) Startech Labs, Inc. A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Startech Labs, Inc. and will be retained by Startech Labs, Inc. and furnished to the Securities and Exchange Commission or its staff upon request. 

</EX-32.1>

<EX-101.SCH>
 4
 laab-20241130.xsd
 XBRL TAXONOMY EXTENSION SCHEMA

</EX-101.LAB>

<EX-101.CAL>
 6
 laab-20241130_cal.xml
 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE

</EX-101.CAL>

<EX-101.PRE>
 7
 laab-20241130_pre.xml
 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

</EX-101.PRE>

<EX-101.DEF>
 8
 laab-20241130_def.xml
 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

</EX-101.DEF>

